Ligand validation:5MWL

5MY: MYO-INOSITOL-(1,3,4,5,6)-PENTAKISPHOSPHATE

5MY is a Ligand Of Interest in 5MWL designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5MWL_5MY_A_502	8%	54%	0.32	0.786	0.84	0.94	-	1	0	0	100%	1
5MW8_5MY_A_502	73%	55%	0.136	0.965	0.77	0.95	-	1	0	0	100%	1
2XAO_5MY_A_500	96%	52%	0.076	0.985	0.68	1.15	-	5	0	0	100%	1
2XAN_5MY_B_500	91%	56%	0.097	0.985	0.71	0.99	-	2	1	0	100%	1
6FL3_5MY_B_501	86%	47%	0.117	0.987	0.74	1.29	-	7	0	0	100%	1
4O4E_5MY_A_403	55%	37%	0.147	0.914	1.23	1.25	3	4	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.